Improving adherence to medication in stroke survivors (IAMSS): a randomised controlled trial: study protocol
1 Department of Psychology, Stirling University, Stirling, UK
2 Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh, UK
3 Psychology Department, William Guild Building, University of Aberdeen, Aberdeen, UK
BMC Neurology 2010, 10:15 doi:10.1186/1471-2377-10-15Published: 24 February 2010
Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30% of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke.
Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure.
This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention.
Current Controlled Trials ISRCTN38274953